Dataset

Patent grants, applications & citations

Free & Open Data API TSV 1 source

Disambiguated US patent data, inventors, assignees, locations, claims and citation networks, from PatentsView and Patent Examination Research, reaching back to 1976 and including pre-grant publications, all queryable for free.

Dataset card

USPTO PatentsView provides public-domain data on U.S. patent grants, applications, assignees, and citations. It serves as a broad open resource for tracking innovation activity across organizations and inventors.

What this dataset contains

The dataset covers U.S. patent grants and applications sourced from the USPTO, along with citation linkages between patents. It is intended to surface innovation, R&D, and assignee-level activity without any licensing restriction. No specific row counts, time range, or coverage scope are documented in the provided facts.

Structure and fields

The provider does not list a public schema or column names in the supplied description, so the exact fields are not confirmed. Tags reference patents, innovation, R&D, assignees, and citations, suggesting entity-level identifiers for patents and assignees are likely present, but analysts should verify the full schema from the official PatentsView documentation before use.

How analysts use it

Patent filings and citation patterns are commonly used to gauge corporate R&D intensity, identify assignees building defensible technology portfolios, and benchmark competitors in specific technology areas. Plausible investment-fund applications include long/short signal generation on innovation momentum, M&A target screening, and tracking ESG- or thematic-fund exposures to emerging technology domains, though the underlying facts do not demonstrate these uses directly.

Documentation & references 2
  1. USPTO PatentsView/Patent grants, applications & citations: listing on the provider website
  2. USPTO PatentsView: official website

Discussion

Questions or observations about this dataset? Join the conversation on X.

Discuss on X

No comments yet. Start the conversation on X.